Nova Ltd. (NVMI)

Theseus Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 7, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	7,720	5,721	3,940	2,345	4,140	1,982
Market Cap Growth	18.77%	45.19%	68.02%	-43.36%	108.89%	87.34%
Enterprise Value	7,085	5,160	3,574	2,093	3,826	1,783
Last Close Price	262.57	196.95	137.39	81.68	146.50	70.60
PE Ratio	35.66	31.13	28.91	16.73	44.47	41.37
Forward PE	30.48	26.23	27.08	18.66	34.12	31.14
PS Ratio	9.52	8.51	7.61	4.11	9.95	7.36
PB Ratio	7.05	6.17	5.25	4.00	8.74	5.33
P/TBV Ratio	8.08	6.75	5.96	4.74	9.18	5.72
P/FCF Ratio	37.46	26.24	37.05	23.88	32.49	36.83
P/OCF Ratio	33.61	24.32	31.90	19.62	31.30	32.89
EV/Sales Ratio	8.78	7.67	6.90	3.67	9.20	6.62
EV/EBITDA Ratio	28.05	25.18	24.07	12.72	31.54	27.88
EV/EBIT Ratio	30.33	27.51	27.02	13.96	34.05	32.08
EV/FCF Ratio	34.38	23.66	33.61	21.31	30.02	33.13
Debt / Equity Ratio	0.19	0.25	0.33	0.42	0.47	0.58
Debt / EBITDA Ratio	0.80	1.11	1.57	1.44	1.76	3.13
Debt / FCF Ratio	1.01	1.08	2.30	2.51	1.73	3.99
Asset Turnover	0.58	0.53	0.49	0.64	0.57	0.51
Inventory Turnover	2.05	1.94	1.76	2.60	2.57	2.15
Quick Ratio	1.98	1.87	1.72	3.61	1.67	8.00
Current Ratio	2.57	2.32	2.20	4.57	1.97	9.17
Return on Equity (ROE)	24.23%	21.89%	20.38%	26.44%	22.03%	13.96%
Return on Assets (ROA)	10.50%	9.29%	7.81%	10.47%	9.62%	6.58%
Return on Capital (ROIC)	12.22%	10.86%	9.04%	12.27%	10.97%	7.44%
Return on Capital Employed (ROCE)	19.70%	18.70%	16.30%	17.60%	21.70%	9.30%
Earnings Yield	3.04%	3.21%	3.46%	5.98%	2.25%	2.42%
FCF Yield	2.67%	3.81%	2.70%	4.19%	3.08%	2.71%
Buyback Yield / Dilution	0.60%	-0.15%	-0.69%	-6.89%	-2.99%	-1.31%

Updated Aug 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q